202 related articles for article (PubMed ID: 23359122)
1. Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.
Schiedel AC; Lacher SK; Linnemann C; Knolle PA; Müller CE
Purinergic Signal; 2013 Sep; 9(3):351-65. PubMed ID: 23359122
[TBL] [Abstract][Full Text] [Related]
2. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
[TBL] [Abstract][Full Text] [Related]
3. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
Deb PK; Deka S; Borah P; Abed SN; Klotz KN
Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.
Liang BT; Haltiwanger B
Circ Res; 1995 Feb; 76(2):242-51. PubMed ID: 7834835
[TBL] [Abstract][Full Text] [Related]
5. The role of activated adenosine receptors in degranulation of human LAD2 mast cells.
Leung CT; Li A; Banerjee J; Gao ZG; Kambayashi T; Jacobson KA; Civan MM
Purinergic Signal; 2014 Sep; 10(3):465-75. PubMed ID: 24595664
[TBL] [Abstract][Full Text] [Related]
6. Contractile effects and receptor analysis of adenosine-receptors in human detrusor muscle from stable and neuropathic bladders.
Pakzad M; Ikeda Y; McCarthy C; Kitney DG; Jabr RI; Fry CH
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):921-9. PubMed ID: 27185496
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
Gessi S; Varani K; Merighi S; Morelli A; Ferrari D; Leung E; Baraldi PG; Spalluto G; Borea PA
Br J Pharmacol; 2001 Sep; 134(1):116-26. PubMed ID: 11522603
[TBL] [Abstract][Full Text] [Related]
8. Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.
Sanjani MS; Teng B; Krahn T; Tilley S; Ledent C; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2322-33. PubMed ID: 21949117
[TBL] [Abstract][Full Text] [Related]
9. Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.
Teng B; Fil D; Tilley SL; Ledent C; Krahn T; Mustafa SJ
J Cardiovasc Pharmacol; 2013 Jan; 61(1):70-6. PubMed ID: 23288107
[TBL] [Abstract][Full Text] [Related]
10. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
11. Multiple adenosine receptor subtypes stimulate wound healing in human EA.hy926 endothelial cells.
Bonyanian Z; Walker M; Du Toit E; Rose'Meyer RB
Purinergic Signal; 2019 Sep; 15(3):357-366. PubMed ID: 31254200
[TBL] [Abstract][Full Text] [Related]
12. Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.
Patel M; Sheehan MJ; Strong P
Br J Pharmacol; 1994 Nov; 113(3):741-8. PubMed ID: 7858863
[TBL] [Abstract][Full Text] [Related]
13. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells.
Costa MA; Barbosa A; Neto E; Sá-e-Sousa A; Freitas R; Neves JM; Magalhães-Cardoso T; Ferreirinha F; Correia-de-Sá P
J Cell Physiol; 2011 May; 226(5):1353-66. PubMed ID: 20945394
[TBL] [Abstract][Full Text] [Related]
14. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A
Andrés RM; Terencio MC; Arasa J; Payá M; Valcuende-Cavero F; Navalón P; Montesinos MC
J Invest Dermatol; 2017 Jan; 137(1):123-131. PubMed ID: 27498346
[TBL] [Abstract][Full Text] [Related]
16. Characterization of P1 (adenosine) purinoceptors.
Jarvis MF
Curr Protoc Pharmacol; 2013 Oct; 62():1.9.1-1.9.16. PubMed ID: 24510716
[TBL] [Abstract][Full Text] [Related]
17. A1 adenosine receptors and their ligands: overview and recent developments.
Müller CE
Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971
[TBL] [Abstract][Full Text] [Related]
18. Substituted 4-phenylthiazoles: Development of potent and selective A
Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors.
Fiebich BL; Biber K; Lieb K; van Calker D; Berger M; Bauer J; Gebicke-Haerter PJ
Glia; 1996 Oct; 18(2):152-60. PubMed ID: 8913778
[TBL] [Abstract][Full Text] [Related]
20. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil.
Pospísil M; Hofer M; Vacek A; Znojil V; Pipalová I
Physiol Res; 2004; 53(5):549-56. PubMed ID: 15479134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
